PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21074994-0	2011	Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models.	2,3,4,5-tetrahydro-benzo[d]azepine	6-40	anaplastic lymphoma kinase	Mus musculus	113-116	
21074994-1	2011	The synthesis and biological evaluation of potent and selective anaplastic lymphoma kinase (ALK) inhibitors from a novel class of 2,4-diaminopyrimidines, incorporating 2,3,4,5-tetrahydro-benzo[d]azepine fragments, is described.	2,3,4,5-tetrahydro-benzo[d]azepine	168-202	anaplastic lymphoma kinase	Mus musculus	64-90	
21074994-1	2011	The synthesis and biological evaluation of potent and selective anaplastic lymphoma kinase (ALK) inhibitors from a novel class of 2,4-diaminopyrimidines, incorporating 2,3,4,5-tetrahydro-benzo[d]azepine fragments, is described.	2,3,4,5-tetrahydro-benzo[d]azepine	168-202	anaplastic lymphoma kinase	Mus musculus	92-95